Drug research

5-Fluorouracil

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )NCT07621718	RVMD	Phase 3	Recruiting	2028-12-30Estimated
Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic CancerNCT04390399	IBRX	Phase 2	Active not recruiting	2025-10-13Actual
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal CancersNCT05152147	Jazz Pharmaceuticals	Phase 3	Active not recruiting	2026-07-15Actual

RVMDRecruitingPrimary completion: 2028-12-30 · Estimated

Trial details

IBRXActive not recruitingPrimary completion: 2025-10-13 · Actual

Trial details

Jazz PharmaceuticalsActive not recruitingPrimary completion: 2026-07-15 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.